SCHEDULE: Mubadala Entities Divest Evotec SE Stake
Schedule 13D Amendment
Several Mubadala Investment Company-affiliated entities have reported the complete sale of their ordinary shares and ADSs in Evotec SE, marking a full divestment from the company.
Summary
- Mubadala Investment Company PJSC, Mamoura Diversified Global Holding PJSC, Mubadala Technology Investments LLC, ATIC Second International Investment Company LLC, and Ninety Fourth Investment Company LLC have jointly filed a Schedule 13D amendment.
- These entities report the complete divestment of their holdings in Evotec SE, including ordinary shares and American Depositary Shares (ADSs).
- The sale occurred on October 9, 2026, through a privately negotiated block trade.
- ATIC Second International Investment Company initially purchased shares in a private placement in October 2020 and later ADSs during Evotec's IPO in November 2021.
- An internal reorganization on July 29, 2022, transferred these holdings to Ninety Fourth Investment Company.
- Ninety Fourth Investment Company converted most of its ADSs to ordinary shares before the final sale.
- As of October 9, 2026, none of the reporting persons beneficially own more than five percent of Evotec SE's securities.
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a neutral to slightly negative filing, primarily due to the complete divestment of a significant investment without clear indication of reinvestment strategy.
Positives
- The divestment was executed through a privately negotiated block trade, suggesting a potentially orderly exit.
- The reporting entities are well-established investment companies with a mandate to generate sustainable financial returns.
Negatives
- The complete divestment of the investment in Evotec SE indicates a lack of confidence or a strategic shift away from this particular asset.
- The filing does not provide details on the rationale behind the divestment beyond 'investment purposes' and a desire to 'completely divest'.
Risks
- The filing does not explicitly mention any risks associated with the divestment itself, but the complete exit may signal underlying concerns about Evotec SE's future prospects from the perspective of a major investor.
- The lack of information regarding future investment strategies for the divested capital could be a concern for stakeholders interested in the long-term growth of the Mubadala entities.
Future Outlook
The filing focuses on past transactions and the divestment of an investment. It does not contain specific forward-looking statements or guidance regarding Evotec SE's future performance. The future outlook for the reporting entities is not detailed beyond their general mandate as global investment companies.
Management Comments
- The Reporting Persons have acquired the Shares reported herein for investment purposes.
- The Reporting Persons undertook this sale to completely divest their investment in the Issuer.
Industry Context
StockSavvy.ai notes that this filing represents a significant shift for the reporting entities, indicating a potential reassessment of their investment portfolio. The divestment from Evotec SE, a company in the biotechnology sector, could reflect broader market trends or specific due diligence findings related to Evotec's business or the pharmaceutical/biotech industry.
Related Party Transactions
- ATIC Second International Investment Company LLC transferred its holdings to Ninety Fourth Investment Company LLC as part of an internal reorganization.
Stakeholder Impact
- Shareholders of Evotec SE may see a change in their shareholder base with the exit of a significant investor.
- Stakeholders of the Mubadala entities may be interested in the strategic rationale for the divestment and the reallocation of capital.
Next Steps
- The reporting entities have completed the divestment of their holdings in Evotec SE.
- Further amendments to Schedule 13D will be filed if there are any future changes in beneficial ownership exceeding five percent.
Key Dates
| Date | Description |
|---|---|
| 2020-10-12 | Investment Agreement between ATIC Second International Investment Company and Evotec SE for a private placement. |
| 2020-10-12 | ATIC Second International Investment Company purchased 9,182,652 Ordinary Shares in a private placement. |
| 2021-11-08 | ATIC Second International Investment Company purchased 4,597,701 ADSs in connection with Evotec SE's IPO. |
| 2022-07-29 | ATIC Second International Investment Company transferred its Evotec SE shares and ADSs to Ninety Fourth Investment Company. |
| 2026-05-25 | Ninety Fourth Investment Company converted all but one of its ADSs into Ordinary Shares. |
| 2026-10-09 | Ninety Fourth Investment Company sold all of its Ordinary Shares and its one remaining ADS. |
| 2026-10-14 | Date of signatures on the Joint Filing Agreement and Amendment to Schedule 13D. |
Keywords
Evotec SE, Schedule 13D, Mubadala Investment Company, Divestment, Block Trade, Ordinary Shares, ADSs, Investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.